Preview

Journal Biomed

Advanced search

Safety Profile of a New Dimethylaminoethanol Derivative by Oral Administration to Laboratory Animals

https://doi.org/10.33647/2074-5982-19-3-82-86

Abstract

A new derivative of dimethylaminoethanol, butanedioic and trans-butenedioic acids (laboratory code ADK-17) was synthesized at the Department of Organic Chemistry (Professor I.P. Yakovlev is the Head of the Department) of St. Petersburg State Chemical and Pharmaceutical University (SPCPU). This is a promising compound planned for use as an oral dosage form. In this work, we aim to evaluate manifestations of the general and specific toxicity of the new drug. Laboratory animals (white mice, rats, rabbits, guinea pigs) were used as test systems for the preclinical safety study of the new compound. Manifestations of general toxicity (acute and chronic), local irritant action, allergenic properties, immunotoxic action were studied. The reproductive toxicity of the ADK-17 drug when administered intragastrically was studied. The studied drug was found to exhibit low toxicity, cause no changes in the biochemical and morphological parameters of rats and rabbits under the conditions of course use, and have no negative effects on internal organs. When administered intragastrically in maximum doses, the drug causes no irritating effects. The use of the drug did not lead to the development of a local allergic reaction of an immediate type. Carrying out sensitization in the DTH reaction showed the absence of a sensitizing effect. The study of the immunotoxic effect of the ADK-17 drug showed that its prolonged intragastric administration for 30 days at doses of 93 and 930 mg/kg did not lead to a violation of the humoral immune response and a decrease in antibody production. Setting a delayed-type hypersensitivity reaction also confirms that the drug does not affect the development of cellular immunity. The conducted experimental studies of the drug’s reproductive toxicity in rats showed that its repeated intragastric administration at doses of 50 and 250 mg/kg to pregnant females did not have a negative effect on the reproductive system of laboratory animals, embryo- and fetotoxic, as well as teratogenic effects, having no effect on the antenatal and postnatal development of offspring.

About the Authors

E. B. Shustov
Scientific and Clinical Center of Toxicology named after S.N. Golikov of the Federal Medical and Biological Agency of Russia
Russian Federation

Evgeny B. Shustov, Dr. Sci. (Med.), Prof.

192019, St. Petersburg, Bekhtereva Str., 1



A. E. Kim
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of Russia
Russian Federation

Aleksey E. Kim, Cand. Sci. (Med.), Assoc. Prof.

194044, St. Petersburg, Akademika Lebedeva Str., 6



References

1. Березовская И.В. Прогноз безопасности лекарственных средств в доклинических токсикологических исследованиях. Токсикологический вестник. 2010;5(104):17–22. [Berezovskaja I.V. Prognoz bezopasnosti lekarstvennykh sredstv v doklinicheskikh toksikologicheskikh issledovaniyakh [Prediction of drug safety in preclinical toxicological studies]. Toksikologicheskiy vestnik [Toxicological Review]. 2010;5(104):17–22. (In Russian)].

2. Каркищенко Н.Н. Альтернативы биомедицины. Т. 2. Классика и альтернативы фармакотоксикологии. М.: Изд-во ВПК, 2007:448. [Karkischenko N.N. Al'ternativy biomeditsiny. T. 2. Klassika i al'ternativy farmakotoksikologii [Alternatives to biomedicine. Vol. 2. Classics and alternatives of pharmacotoxicology]. Moscow: VPK Publ., 2007:448. (In Russian)].

3. Руководство по проведению доклинических исследований лекарственных средств. Ч. 1. М.: Гриф и К, 2012:944. [Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv [Guidelines for conducting preclinical studies of drugs]. Part 1. Moscow: Grif i K Publ., 2012:944. (In Russian)].

4. Gosselin R.E., Hodge H.C., Smith R.P., Gleason M.N. Clinical toxicology of commercial products: Acute poisoning. 4th ed. Baltimore: DeWilliams and Wilkins Company, 1976:332.

5. Test No. 421: Reproduction/Developmental Toxicity Screening Test. OECD; 2015:1–27. DOI: 10.1787/ 9789264242692-en.


Review

For citations:


Shustov E.B., Kim A.E. Safety Profile of a New Dimethylaminoethanol Derivative by Oral Administration to Laboratory Animals. Journal Biomed. 2023;19(3):82-86. (In Russ.) https://doi.org/10.33647/2074-5982-19-3-82-86

Views: 236


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-5982 (Print)
ISSN 2713-0428 (Online)